Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal PathLabs has informed that it enclosed the details of proposed schedule of Analyst/ Institutional Investor meeting(s) scheduled on February 17, 2023. Dates of the aforesaid meeting/call are subject to change due to exigencies on the part of Investor/ Company. No Unpublished Price Sensitive Information will be shared during the meetings.
The above information is a part of company’s filings submitted to BSE.
